Phenotypic targeting using magnetic nanoparticles for rapid characterization of cellular proliferation regulators

Area of Science:

• Genomics
• Biotechnology
• Cancer Research

Background:

• Genome-wide CRISPR screens are vital for identifying genetic regulators of cellular phenotypes.
• Traditional screens often rely on live/dead viability readouts, which can be time-consuming.
• There is a need for faster, more efficient screening methods to discover therapeutic targets.

Purpose of the Study:

• To develop and validate a nanoparticle-enabled magnetic sorting approach for CRISPR screens.
• To compare the efficiency of the magnetic workflow against traditional screening methods.
• To identify novel therapeutic targets for mesenchymal cancers by analyzing cell proliferation dependencies.

Main Methods:

• Converting cell proliferation into a measurable degree of magnetization using nanoparticles.
• Employing microfluidic magnetic sorting for downstream analysis of screened cells.
• Performing head-to-head comparisons with traditional CRISPR screens and validating identified targets.

Main Results:

• The magnetic workflow successfully identified the same essential genetic regulators as traditional screens.
• The screening period was significantly reduced from 4 weeks to 1 week.
• Multiple mesenchymal cancer cell lines were screened, revealing both pan-cancer and cell-specific therapeutic targets.

Conclusions:

• The nanoparticle-enabled magnetic approach offers a rapid and efficient alternative for CRISPR screening.
• This method enhances data breadth and accelerates the discovery of potential drug targets for cancer treatment.
• The validated targets represent promising avenues for developing new cancer therapies.